Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Roelandts

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 13, 2005
[Radiation therapy of benign diseases. What's new eight years after?]P Van Houtte, M Roelandts, D Devriendt, et al.
Revue Medicale De Bruxelles|June 22, 2011
[Non Hodgkin's lymphomas: a major breakthrough with immunotherapy]R Firescu, K Muylle, M Roelandts, et al.
Revue Medicale De Bruxelles|November 24, 2015
[Practical approach of lymphomas: major role of general practitioner who has to face all these emerging drugs]D Bron, R Dewind, B Cantinieaux, et al.
Lung Cancer (Amsterdam, Netherlands)|September 23, 2008
A phase III randomised study comparing concomitant radiochemotherapy as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancerT Berghmans, P Van Houtte, M Paesmans, et al.
Lung Cancer (Amsterdam, Netherlands)|January 8, 2004
Critical factors for patient managementV Ninane, C Le Pechoux, W Curran, et al.
The European Respiratory Journal|July 9, 2011
Surrogate markers predicting overall survival for lung cancer: ELCWP recommendationsT Berghmans, F Pasleau, M Paesmans, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 13, 2005
[Radiation therapy of benign diseases. What's new eight years after?]P Van Houtte, M Roelandts, D Devriendt, et al.
Revue Medicale De Bruxelles|June 22, 2011
[Non Hodgkin's lymphomas: a major breakthrough with immunotherapy]R Firescu, K Muylle, M Roelandts, et al.
Revue Medicale De Bruxelles|November 24, 2015
[Practical approach of lymphomas: major role of general practitioner who has to face all these emerging drugs]D Bron, R Dewind, B Cantinieaux, et al.
Lung Cancer (Amsterdam, Netherlands)|September 23, 2008
A phase III randomised study comparing concomitant radiochemotherapy as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancerT Berghmans, P Van Houtte, M Paesmans, et al.
Lung Cancer (Amsterdam, Netherlands)|January 8, 2004
Critical factors for patient managementV Ninane, C Le Pechoux, W Curran, et al.
The European Respiratory Journal|July 9, 2011
Surrogate markers predicting overall survival for lung cancer: ELCWP recommendationsT Berghmans, F Pasleau, M Paesmans, et al.
Pageof 2